Guidelines     MGP Ltd



Forthcoming guidance
 
Published guidance
 
Select guidance type:
Select Clinical speciality:

Date: from to

Search



Title Type Clinical speciality   Published date   Review Date
Child abuse and neglect NICE Quality Standard Paediatrics Feb 2019 -
Serious eye disorders NICE Quality Standard Eye, ear, nose and throat Feb 2019 -
Sexual health NICE Quality Standard Sexual health Feb 2019 -
Nivolumab for adjuvant treatment of completely resected melanoma with lymph node involvement or metastatic disease NICE Technology Appraisal Cancer Jan 2019 -
Axicabtagene ciloleucel for treating diffuse large B-cell lymphoma and primary mediastinal large B-cell lymphoma after 2 or more systemic therapies NICE Technology Appraisal Cancer Jan 2019 -
Pembrolizumab with pemetrexed and platinum chemotherapy for untreated, metastatic, non-squamous non-small-cell lung cancer NICE Technology Appraisal Cancer Jan 2019 -
Darvadstrocel for treating perianal fistula in Crohn's disease NICE Technology Appraisal Gastrointestinal Jan 2019 -
Regorafenib for previously treated advanced hepatocellular carcinoma NICE Technology Appraisal Cancer Jan 2019 -
Renal and ureteric stones: assessment and management NICE Clinical Guideline Renal conditions Jan 2019 -
Combined hormonal contraception—update (Faculty of Sexual & Reproductive Healthcare) Independent professional body guideline Sexual health Jan 2019 -
Tisagenlecleucel for treating relapsed or refractory B-cell acute lymphoblastic leukaemia in people aged up to 25 years NICE Technology Appraisal Cancer Dec 2018 -
dolutegravir/rilpivirine (Juluca®) All Wales Medicines Strategy Group appraisal Infection Dec 2018 -
brivaracetam (Briviact®) All Wales Medicines Strategy Group appraisal Neurology Dec 2018 -
Pembrolizumab for adjuvant treatment of melanoma with high risk of recurrence NICE Technology Appraisal Cancer Dec 2018 -
Pancreatic cancer NICE Quality Standard Cancer Dec 2018 -
Lenvatinib for advanced, unresectable, untreated hepatocellular carcinoma NICE Technology Appraisal Cancer Dec 2018 -
Liposomal cytarabine and daunorubicin for untreated acute myeloid leukaemia NICE Technology Appraisal Cancer Dec 2018 -
Vandetanib for treating medullary thyroid cancer NICE Technology Appraisal Cancer Dec 2018 -
Oesophago-gastric cancer NICE Quality Standard Cancer Dec 2018 -
nivolumab (Opdivo) SMC advice Cancer Dec 2018 -
ciclosporin (Verkazia) SMC advice Eye, ear, nose and throat Dec 2018 -
ocrelizumab (Ocrevus) SMC advice Neurology Dec 2018 -
pembrolizumab (Keytruda) SMC advice Cancer Dec 2018 -
pertuzumab (Perjeta) SMC advice Cancer Dec 2018 -
brivaracetam (Briviact) SMC advice Neurology Dec 2018 -
Denosumab for preventing skeletal-related events in multiple myeloma (terminated appraisal) NICE Technology Appraisal Cancer Dec 2018 -
fosaprepitant (Ivemend®) All Wales Medicines Strategy Group appraisal Gastrointestinal Dec 2018 -
fosaprepitant (Ivemend®) All Wales Medicines Strategy Group appraisal Cancer Dec 2018 -
bictegravir/emtricitabine/tenofovir alafenamide (Biktarvy®) All Wales Medicines Strategy Group appraisal Infection Dec 2018 -
tiotropium (Spiriva® Respimat®) All Wales Medicines Strategy Group appraisal Respiratory Dec 2018 -
Chronic obstructive pulmonary disease in over 16s: diagnosis and management (update) NICE Clinical Guideline Respiratory Dec 2018 -
Post-traumatic stress disorder NICE Clinical Guideline Neurology Dec 2018 -
Chronic obstructive pulmonary disease (acute exacerbation): antimicrobial prescribing NICE Clinical Guideline Respiratory Dec 2018 -
Tofacitinib for moderately to severely active ulcerative colitis NICE Technology Appraisal Gastrointestinal Nov 2018 -
Padeliporfin for untreated localised prostate cancer NICE Technology Appraisal Cancer Nov 2018 -
Gemtuzumab ozogamicin for untreated acute myeloid leukaemia NICE Technology Appraisal Cancer Nov 2018 -
evolocumab (Repatha) SMC advice Cardiovascular Nov 2018 -
fosaprepitant (IVEMEND) SMC advice Cancer Nov 2018 -
fampridine (Fampyra) SMC advice Musculoskeletal and joints Nov 2018 -
atezolizumab (Tecentriq) SMC advice Cancer Nov 2018 -